COVID-19 treatment

People do not need to buy or sell plasma

Mylan received license from Gilead for commercialisation of Remdesivir

Software has been developed for this purpose, trial run is being conducted to eliminate any shortcoming: Binay Bhushan

The packages are based on Clinical Care guidelines issued by Ministry of Health & Family Welfare

This means that instead of manually going through available drugs, checking its effectiveness against COVID-19, AI can speed…

According to DCGI suggestion, companies must put in place a 24x7 helpline where the patients or their family members could contact…

The drug is currently used intravenously and an inhaled formulation would be given through a nebuliser Gilead Sciences has…

The drug will be available through the government and hospitals only Cipla has priced its generic version of remdesivir,…

Li-Fi is more suitable in-hospital application for monitoring patient's conditions without frequency interference with human body…

The clinical trial named MUCOVIN, to be carried out in the partnership with Medanta Medicity Council of Scientific &…